Article
It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.
All News
Article
Mayo Clinic Proceedings reports the results of a retrospective, cross-sectional of patients with HFE hemochromatosis showing that advanced hepatic fibrosis is primarily seen in those with arthritis due to HFE hemochromatosis.
Article
Dr. Jack Cush discusses the news and recent journal reports from last weeks RheumNow.com, and answers viewer questions from #ACA - Ask Cush Anything.
Dr. John Cush
Tweet
Systematic literature review of studies where steroids were used as initial "Bridge Therapy" in RA patients - included 10 studies, but only 4 RCTs w/ protocolized discontinuation - these showed 22% were still on GC @ 12 mos, 10% @24 mos https://t.co/aRLhptAASe https://t.co/lg4msIyQfc
Dr. John Cush
Tweet
Watch: Dr. Ritchlin discusses Future Discovery and Targets.
https://t.co/MOQjXWd6tc https://t.co/EQWBnL9jzI
Dr. John Cush
Tweet
Spanish BIOBADASER registry real world performance of secukinumab in 639 pts w/ #PsA & spondyloarthritis (axSpA, AS, NR axSpA) showed imprved Dz activity at 1 yr & maintained or increased 2 & 3 years. Retention rates best when SEC used 1st biologic https://t.co/MAE3BhLlRg
Dr. John Cush
Tweet
Cardiovascular risk (CVR) was assessed in Psoriasis (#PSO) & #PSA in multiracial population in S Brazil using the Framingham Risk Score. Compared to controls PSO & PSA had higher FRS (16.3 & 18 vs 10.6) and also increased with age. highttps://bit.ly/3k7ySi8
Dr. John Cush
Tweet
FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv
Dr. John Cush
Tweet
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z
Dr. John Cush
Tweet
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal complaints, 85% were dx w/ PsA - 62% of these PsA was 1st diagnosed. https://t.co/RcQrWaXTWj
Dr. John Cush
Tweet
QD Clinic - PsA lessons and cases from the Rheumatology clinic.
Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult
https://t.co/UCcCMqUL2d https://t.co/zLkfBYI4Cm
Dr. John Cush
Tweet
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/ZucrYKuNms
Dr. John Cush
Tweet
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!
Speakers will include:
Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush
https://t.co/by1xtmPSZ0
You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/o633KHx81b
Dr. John Cush
Tweet
ICYMI:Faith in Exercise Benefit Boosts Actual Benefit in SpA
https://t.co/kEErN5IZUI https://t.co/9ve0ey9MRp
Dr. John Cush
Tweet
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to grow to $40.13 billion by 2027. https://t.co/JDzkYFENFc
Dr. John Cush
Tweet
ICYMI: Axial Disease in Psoriatic Arthritis
Inflammatory involvement of the axial skeleton and sacroiliac joints occurs, on average, in 40-50% of patients with psoriatic arthritis (PsA).
https://t.co/QKtpSPDz5V https://t.co/ROz5o9OTyZ
Dr. John Cush
Tweet
QD clinic - PsA Lessons from Patients
Enthesitis in a 14 yr.old - management and evolutionary possibilities
https://t.co/MtgoDXJ7EF https://t.co/sTFyySF4vl
Dr. John Cush
Tweet
Did you missed this past Tuesday Night Rheumatology? We have the playback available now.
The PsA Expert panelists included: Dr. Dafna Gladman Dr. Joseph Merola, Dr. Peter Nash, Dr. Christopher Ritchlin, Dr. Jose Scher and Dr. Jack Cush.
https://t.co/u5lt2uDoGK https://t.co/lOmN4OoGLi
Dr. John Cush
Tweet
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/fIHAhpvVho https://t.co/6tFbQd0vJQ
Dr. John Cush
Tweet
Taiwan claims data shows among 2050 new SLE, 783 on HCQ. HCQ had no effect on future development of CKD over 14 yrs. Yet some rec HCQ in all lupus nephritis to reduce kidney flares, ESKD and death. https://t.co/JS0ST1W0LW https://t.co/ihQp3d5rcy
